Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,948 | 61,027 | 105,854 | 44,313 | 163,888 |
| Marketable Securities | 223,120 | 240,102 | 347,314 | 200,397 | 156,094 |
| Receivables | 858 | 8,213 | 13,659 | 247 | 9,949 |
| Other current assets | 5,384 | 4,473 | 4,982 | 3,137 | 1,584 |
| TOTAL | $279,310 | $313,815 | $471,809 | $248,094 | $331,515 |
| Non-Current Assets | |||||
| PPE Net | 99,307 | 102,166 | 56,236 | 14,102 | 12,088 |
| Intangibles | 0 | 0 | 0 | 0 | 188 |
| Other Non-Current Assets | 104,506 | 103,236 | 26,910 | 4,343 | 2,559 |
| TOTAL | $203,813 | $205,402 | $83,146 | $18,445 | $14,835 |
| Total Assets | $483,123 | $519,217 | $554,955 | $266,539 | $346,350 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,814 | 6,674 | 3,960 | 2,658 | 149 |
| Accounts payable and accrued liabilities | 3,447 | 5,391 | 1,295 | 1,959 | 1,539 |
| Accrued Expenses | 17,895 | 19,846 | 55,091 | 22,163 | 15,753 |
| TOTAL | $33,693 | $59,585 | $110,012 | $32,479 | $24,761 |
| Non-Current Liabilities | |||||
| Long Term Debt | 53,590 | 59,452 | 32,473 | 5,277 | N/A |
| Deferred Revenues | 6,537 | 27,674 | 49,666 | 5,699 | 5,382 |
| Other Non-Current Liabilities | 5,736 | 4,353 | 3,109 | 3,696 | 3,179 |
| TOTAL | $59,326 | $65,805 | $53,823 | $9,806 | $11,196 |
| Total Liabilities | $93,019 | $125,390 | $163,835 | $42,285 | $35,957 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,209 | 36,597 | 35,334 | 30,720 | 30,400 |
| Common Shares | 37 | 37 | 35 | 31 | 30 |
| Retained earnings | -300,146 | -277,955 | -232,182 | -201,926 | -107,390 |
| Other shareholders' equity | -1,504 | -2,289 | 741 | 2,065 | -2,265 |
| TOTAL | $390,104 | $393,827 | $391,120 | $224,254 | $310,393 |
| Total Liabilities And Equity | $483,123 | $519,217 | $554,955 | $266,539 | $346,350 |